Market Cap
US$4.2b
Last Updated
2020/02/20 00:04 UTC
Data Sources
Company Financials +
Executive Summary
Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company worldwide.
Rewards
Risk Analysis
Snowflake Analysis
Flawless balance sheet with proven track record.
Similar Companies
Share Price & News
How has Exponent's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: EXPO's share price has been volatile over the past 3 months.
Market Performance
7 Day Return
3.7%
EXPO
1.4%
US Professional Services
0.5%
US Market
1 Year Return
45.6%
EXPO
31.4%
US Professional Services
20.3%
US Market
Return vs Industry: EXPO exceeded the US Professional Services industry which returned 31.4% over the past year.
Return vs Market: EXPO exceeded the US Market which returned 20.3% over the past year.
Shareholder returns
| EXPO | Industry | Market | |
|---|---|---|---|
| 7 Day | 3.7% | 1.4% | 0.5% |
| 30 Day | 14.1% | 3.8% | 2.0% |
| 90 Day | 33.9% | 14.0% | 9.4% |
| 1 Year | 47.2%45.6% | 32.6%31.4% | 22.8%20.3% |
| 3 Year | 191.8%182.2% | 63.6%58.3% | 50.1%40.4% |
| 5 Year | 302.1%278.7% | 83.3%73.3% | 73.1%54.1% |
Price Volatility Vs. Market
How volatile is Exponent's share price compared to the market and industry in the last 5 years?
Simply Wall St News
5 days ago | Simply Wall St
Have Exponent, Inc. (NASDAQ:EXPO) Insiders Been Selling Their Stock?1 week ago | Simply Wall St
Exponent, Inc. Just Released Its Annual Earnings: Here's What Analysts Think3 weeks ago | Simply Wall St
Is Exponent's (NASDAQ:EXPO) 252% Share Price Increase Well Justified?Valuation
Is Exponent undervalued compared to its fair value and its price relative to the market?
52.61x
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: EXPO ($82.34) is trading above our estimate of fair value ($43.55)
Significantly Below Fair Value: EXPO is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: EXPO is poor value based on its PE Ratio (52.6x) compared to the Professional Services industry average (20.5x).
PE vs Market: EXPO is poor value based on its PE Ratio (52.6x) compared to the US market (18.3x).
Price to Earnings Growth Ratio
PEG Ratio: EXPO is poor value based on its PEG Ratio (8.6x)
Price to Book Ratio
PB vs Industry: EXPO is overvalued based on its PB Ratio (12.4x) compared to the US Professional Services industry average (2.7x).
Next Steps
Future Growth
How is Exponent forecast to perform in the next 1 to 3 years based on estimates from 6 analysts?
6.1%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: EXPO's forecast earnings growth (6.1% per year) is above the savings rate (1.7%).
Earnings vs Market: EXPO's earnings (6.1% per year) are forecast to grow slower than the US market (14.2% per year).
High Growth Earnings: EXPO's earnings are forecast to grow, but not significantly.
Revenue vs Market: EXPO's revenue (5.9% per year) is forecast to grow slower than the US market (7.6% per year).
High Growth Revenue: EXPO's revenue (5.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if EXPO's Return on Equity is forecast to be high in 3 years time
Next Steps
Past Performance
How has Exponent performed over the past 5 years?
14.0%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: EXPO has a high level of non-cash earnings.
Growing Profit Margin: EXPO's current net profit margins (21.1%) are higher than last year (20.4%).
Past Earnings Growth Analysis
Earnings Trend: EXPO's earnings have grown by 14% per year over the past 5 years.
Accelerating Growth: EXPO's earnings growth over the past year (13.9%) is below its 5-year average (14% per year).
Earnings vs Industry: EXPO earnings growth over the past year (13.9%) exceeded the Professional Services industry 10.6%.
Return on Equity
High ROE: EXPO's Return on Equity (23.5%) is considered high.
Return on Assets
Return on Capital Employed
Next Steps
Financial Health
How is Exponent's financial position?
Financial Position Analysis
Short Term Liabilities: EXPO's short term assets ($364.0M) exceed its short term liabilities ($124.0M).
Long Term Liabilities: EXPO's short term assets ($364.0M) exceed its long term liabilities ($89.2M).
Debt to Equity History and Analysis
Debt Level: EXPO is debt free.
Reducing Debt: EXPO has not had any debt for past 5 years.
Debt Coverage: EXPO has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: EXPO has no debt, therefore coverage of interest payments is not a concern.
Balance Sheet
Inventory Level: EXPO has a low level of unsold assets or inventory.
Debt Coverage by Assets: Insufficient data to determine if EXPO's debt is covered by short term assets.
Next Steps
Dividend
What is Exponent's current dividend yield, its reliability and sustainability?
0.92%
Current Dividend Yield
Upcoming Dividend Payment
Purchase Exponent before the 'Buy Limit' to receive their next dividend payment.
Dividend Yield vs Market
Current dividend yield vs market & industry
Notable Dividend: EXPO's dividend (0.92%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.44%).
High Dividend: EXPO's dividend (0.92%) is low compared to the top 25% of dividend payers in the US market (3.73%).
Stability and Growth of Payments
Stable Dividend: Whilst dividend payments have been stable, EXPO has been paying a dividend for less than 10 years.
Growing Dividend: EXPO's dividend payments have increased, but the company has only paid a dividend for 7 years.
Current Payout to Shareholders
Dividend Coverage: With its reasonably low payout ratio (40.9%), EXPO's dividend payments are well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: EXPO's dividends in 3 years are forecast to be well covered by earnings (41.3% payout ratio).
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
16.3yrs
Average management tenure
CEO
Catherine Corrigan (50yo)
1.8yrs
Tenure
US$2,143,065
Compensation
Dr. Catherine Ford Corrigan, Ph. D., PE, has been the President of Exponent Inc. since July 29, 2016 and its Chief Executive Officer and Director since May 31, 2018. She served as Group Vice President of T ...
CEO Compensation Analysis
Compensation vs Market: Catherine's total compensation ($USD2.14M) is below average for companies of similar size in the US market ($USD4.89M).
Compensation vs Earnings: Catherine's compensation has been consistent with company performance over the past year.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 1.8yrs | US$2.43m | 0.090% $3.8m | |
| President | 1.8yrs | US$2.14m | 0.10% $4.3m | |
| Executive VP | 20.6yrs | US$1.83m | 0.47% $19.8m | |
| Chief Human Resources Officer | 2.8yrs | US$980.14k | 0.015% $635.6k | |
| Group VP & Principal Engineer | 21.1yrs | US$879.05k | 0.011% $476.5k | |
| Group VP & Principal Engineer | 12.1yrs | US$1.42m | 0.064% $2.7m | |
| Co-Founder | 0yrs | no data | no data | |
| CTO & Principal Engineer | 21.3yrs | US$697.53k | no data | |
| VP & Corporate Controller | 0yrs | no data | no data | |
| Corporate VP of Materials & Corrosion Engineering and Principal Engineer | 30.1yrs | US$393.26k | no data |
16.3yrs
Average Tenure
59yo
Average Age
Experienced Management: EXPO's management team is seasoned and experienced (16.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 1.8yrs | US$2.43m | 0.090% $3.8m | |
| President | 1.8yrs | US$2.14m | 0.10% $4.3m | |
| Co-Founder | 0yrs | no data | no data | |
| Lead Independent Director | 1.8yrs | US$221.58k | 0.13% $5.3m | |
| Independent Director | 5.8yrs | US$217.83k | 0.039% $1.6m | |
| Independent Director | 3yrs | US$205.75k | 0.011% $456.8k | |
| Independent Director | 6.2yrs | US$217.83k | 0.045% $1.9m |
2.4yrs
Average Tenure
64yo
Average Age
Experienced Board: EXPO's board of directors are not considered experienced ( 2.4 years average tenure), which suggests a new board.
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: EXPO insiders have sold more shares than they have bought in the past 3 months.
Recent Insider Transactions
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
Exponent, Inc.'s company bio, employee growth, exchange listings and data sources
Key Information
- Name: Exponent, Inc.
- Ticker: EXPO
- Exchange: NasdaqGS
- Founded: 1967
- Industry: Research and Consulting Services
- Sector: Commercial Services
- Market Cap: US$4.187b
- Shares outstanding: 51.83m
- Website: https://www.exponent.com
Number of Employees
Location
- Exponent, Inc.
- 149 Commonwealth Drive
- Menlo Park
- California
- 94025
- United States
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| EXPO | NasdaqGS (Nasdaq Global Select) | Yes | Common Stock | US | USD | Aug 1990 |
| EP5 | DB (Deutsche Boerse AG) | Yes | Common Stock | DE | EUR | Aug 1990 |
Biography
Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company worldwide. Its services include analysis of product development, product recall, regulatory compliance, and the discovery of potential problems related to products, people, property, and impending litigation. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, electrical engineering and computer science, human factors, industrial structures, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, statistical and data sciences, thermal sciences, and vehicle analysis. The Environmental and Health segment offers services in the areas of chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences, and health sciences. The company offers approximately 90 different technical disciplines to solve complicated issues facing industry and government. It serves clients in chemical, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation, and other sectors of the economy. The company was formerly known as The Failure Group, Inc. and changed its name to Exponent, Inc. in 1998. Exponent, Inc. was founded in 1967 and is headquartered in Menlo Park, California.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2020/02/20 00:04 |
| End of Day Share Price | 2020/02/19 00:00 |
| Earnings | 2020/01/03 |
| Annual Earnings | 2020/01/03 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.